Details for New Drug Application (NDA): 208993
✉ Email this page to a colleague
NDA 208993 describes COLCHICINE, which is a drug marketed by Annora Pharma, Aurobindo Pharma Ltd, Endo Operations, Granules, Alkem Labs Ltd, Amneal Pharms, Dr Reddys, Hetero Labs Ltd V, Mylan, Strides Pharma, Watson Labs Inc, and Zydus Pharms, and is included in fifteen NDAs. It is available from twenty-seven suppliers. Additional details are available on the COLCHICINE profile page.
The generic ingredient in COLCHICINE is colchicine. There are sixteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the colchicine profile page.
The generic ingredient in COLCHICINE is colchicine. There are sixteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the colchicine profile page.
Summary for 208993
| Tradename: | COLCHICINE |
| Applicant: | Hetero Labs Ltd V |
| Ingredient: | colchicine |
| Patents: | 0 |
Pharmacology for NDA: 208993
| Mechanism of Action | Cytochrome P450 3A4 Inhibitors P-Glycoprotein Interactions |
Medical Subject Heading (MeSH) Categories for 208993
Suppliers and Packaging for NDA: 208993
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| COLCHICINE | colchicine | TABLET;ORAL | 208993 | ANDA | Camber Pharmaceuticals, Inc. | 31722-899 | 31722-899-01 | 100 TABLET, FILM COATED in 1 BOTTLE (31722-899-01) |
| COLCHICINE | colchicine | TABLET;ORAL | 208993 | ANDA | Camber Pharmaceuticals, Inc. | 31722-899 | 31722-899-30 | 30 TABLET, FILM COATED in 1 BOTTLE (31722-899-30) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 0.6MG | ||||
| Approval Date: | Aug 13, 2021 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
